Medical Weight Loss for Newport, Rhode Island Residents

Newport, Rhode Island residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Newport through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Private and discreet across Rhode Island: there is no local Newport office to walk into and no one to run into, your entire program runs through secure video and direct shipping. Doctor review just $119 (medication separate).

Why Newport Residents Choose New Hope Weight Loss

For Newport patients who want a doctor genuinely involved, this is the right fit. Compounded semaglutide and tirzepatide are powerful tools, but they are not for everyone, and Dr. Anjmun Sharma treats them that way. She looks at your labs, your medications, and your goals before anything is prescribed, then keeps adjusting as your body responds. These medications are not FDA-approved and results vary, which is exactly why physician oversight matters this much.

From our Costa Mesa, California practice, we provide Newport with physician-supervised GLP-1 care entirely by telehealth. Treatment is prescribed only after Dr. Sharma's review, and medication ships discreetly to your door.

New Hope Weight Loss is based in Costa Mesa, yet a patient in Newport sees the same doctor, takes the same approach, and pays the same prices, all through telehealth across Rhode Island. We care for patients throughout downtown Newport, the historic mansions, and Aquidneck Island. We bill the $119 physician visit clearly and keep your medication billed separately, so the cost is transparent before anything ships to Rhode Island.

Because your care happens by telehealth, there is no waitlist to clear and most Newport patients can have their physician visit scheduled within the same week. Getting started in Newport is simple: a Rhode Island licensed physician reviews your health history for $119, and your medication is billed separately if you are approved. Though Rhode Island is the smallest state, our reach there is complete: New Hope Weight Loss cares for patients statewide by telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

Semaglutide: the 90-Day Metabolic Reset

If you live in Newport and want a clear starting point, this is it. Semaglutide, the active ingredient also used in Wegovy and Ozempic, costs from $166 per month or $499 for the 90-day program. Branded-drug trials showed roughly 15 to 17 percent average weight loss. Compounded semaglutide is not FDA-approved and not brand-identical, so results vary.

Tirzepatide: the dual GLP-1 and GIP option

For patients who want a second lever, tirzepatide starts at $233 per month and acts on both GLP-1 and GIP receptors. Up to 22.5 percent body-weight loss appeared in branded-drug trials at qualifying doses, which is not typical. It shares an active ingredient with Mounjaro and Zepbound.

A $119 physician review is required up front. Medication billed separately. HSA, FSA, Klarna, and Affirm are accepted.

How Telehealth Works for Newport

Getting started in Newport is simple, and you never have to leave home. Begin with a short intake quiz about your health history, weight goals, and any medications you take. Dr. Anjmun Sharma reviews your answers and meets you by secure video, usually within 48 hours, to talk through whether compounded semaglutide or tirzepatide is a reasonable fit. If she prescribes, a state-licensed 503(a) pharmacy ships your medication straight to your Newport address in cold-pack packaging that keeps it stable in transit. From there, your follow-up visits happen by video too, so dose checks and questions stay easy no matter where in you live.

Frequently Asked Questions, Newport

I am searching for weight loss care near Newport. Where are you?

We are based in Costa Mesa, California, where our only physical clinic operates. Patients in Newport, Rhode Island connect with us by telehealth instead of visiting. Dr. Anjmun Sharma conducts a video consult to review your goals and confirm whether you qualify for a compounded GLP-1 medication program.

Do I need to be seen in person if I live in Newport?

Not at all. The telehealth format covers Newport patients from start to finish, so no clinic visit is ever required. You speak with Dr. Sharma by video, and once you are approved, compounded medication ships to Newport in cold-pack packaging built to keep it cool and stable.

What are the program costs for Newport patients?

The physician review is priced at $119. Compounded semaglutide is available from $166 a month or $499 for the 90-day plan, and tirzepatide from $233 a month. Medication is invoiced separately. Payment options include HSA, FSA, Klarna, and Affirm, and Newport patients face no distance surcharge.

What areas of Newport do you serve?

We serve patients from across Newport by telehealth, including downtown Newport, the historic mansions, and Aquidneck Island.

How does telehealth treatment work for Newport patients?

You complete the online medical intake, Dr. Sharma reviews your history by secure video, typically within 48 hours, and if you are a candidate and telehealth-eligible, compounded medication ships to your Newport address. Follow-ups also happen by video.

Newport Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Newport, Rhode Island by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.